Two genes linked to shorter survival in glioblastoma
Original title: NOTCH1 and ADORA3 define a novel transdifferentiation-related prognostic index for prognostic stratification in glioblastoma by integrating clinical factors.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This used old patient records and tests on cells in a dish, not a new treatment in people.
The short version
Scientists found two genes that may help predict how a glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary will behave.
What was studied. Researchers looked at gene and health records from people with glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary in four large databases. They checked 12 genes tied to tumor cells acting like blood vessel cells.
What they found. Two of the genes, called NOTCH1 and ADORA3, were linked to shorter survival. The team built a score from these two genes and added age and chemo status. The score helped sort people into higher and lower risk groups. In lab dishes, switching off either gene made glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary cells less able to form tube shapes.
What this means, and what it doesn't
What it could mean: Someday a test like this might help doctors guess how fast a tumor may grow. It also gives scientists two new targets to study for future drugs.
What it doesn't mean: This is not a new treatment, and it is not a cure. No patient was given a new drug. The work used past health records and tests on cells in a dish. It does not change care today. Years of more study are needed before it could help anyone.
Source: PubMed, October 12, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.